# Novartis AG — Patents explained on PatentBrief

Novartis AG has 2 landmark patents explained in plain English on PatentBrief.

- [How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint](https://patentbrief.org/patent/us/10472419/keytruda-pembrolizumab) — granted 2019
  A patent describing specific genetic blueprints for antibodies designed to bind to and inhibit the TIM-3 protein, a key target in cancer and immune system research.
- [How to Keep High-Concentration Antibody Medicines Stable in Liquid Form](https://patentbrief.org/patent/us/7740842/herceptin-adjuvant-therapy) — granted 2010
  Novartis's patent describes a specific liquid recipe for keeping high concentrations of E25 anti-IgE antibodies stable and usable for medical injections.

**Full profile:** https://patentbrief.org/company/novartis-ag

---

_Source: PatentBrief — https://patentbrief.org. Plain-English explanations of US patents._